Crossmark

Enhancing the discovery and development of immunotherapies for cancer using quantitative and systems pharmacology: Interleukin-12 as a case study

Crossref DOI link: https://doi.org/10.1186/s40425-015-0069-x

Published Online: 2015-06-16

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Klinke, David J https://orcid.org/0000-0003-3299-4938
Funding

Funding for this research was provided by:

National Institutes of Health (0000-0003-3299-4938)

National Science Foundation (0000-0003-3299-4938)
License Information

License valid from 2015-06-16
More Information

Article History

Received: 14 January 2015

Accepted: 28 April 2015

First Online: 16 June 2015